{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:06:12Z","timestamp":1787753172589,"version":"build-2784847793"},"reference-count":65,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University","award":["GRANT618"],"award-info":[{"award-number":["GRANT618"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Protein kinases are seen as promising targets in controlling cell proliferation and survival in treating cancer where fused thiophene synthon was utilized in many kinase inhibitors approved by the FDA. Accordingly, this work focused on adopting fused thienopyrrole and pyrrolothienopyrimidine scaffolds in preparing new inhibitors, which were evaluated as antiproliferative agents in the HepG2 and PC-3 cell lines. The compounds 3b (IC50 = 3.105 and 2.15 \u03bcM) and 4c (IC50 = 3.023 and 3.12 \u03bcM) were the most promising candidates on both cells with good selective toxicity-sparing normal cells. A further mechanistic evaluation revealed promising kinase inhibitory activity, where 4c inhibited VEGFR-2 and AKT at IC50 = 0.075 and 4.60 \u03bcM, respectively, while 3b showed IC50 = 0.126 and 6.96 \u03bcM, respectively. Moreover, they resulted in S phase cell cycle arrest with subsequent caspase-3-induced apoptosis. Lastly, docking studies evaluated the binding patterns of these active derivatives and demonstrated a similar fitting pattern to the reference ligands inside the active sites of both VEGFR-2 and AKT (allosteric pocket) crystal structures. To conclude, these thiophene derivatives represent promising antiproliferative leads inhibiting both VEGFR-2 and AKT and inducing apoptosis in liver cell carcinoma.<\/jats:p>","DOI":"10.3390\/ph15060700","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:05:02Z","timestamp":1654167902000},"page":"700","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2\/AKT Dual Inhibitors and Apoptosis Inducers"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-2240","authenticated-orcid":false,"given":"Rana M.","family":"Abdelnaby","sequence":"first","affiliation":[{"name":"Pharmaceutical Chemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-425X","authenticated-orcid":false,"given":"Afaf A.","family":"El-Malah","sequence":"additional","affiliation":[{"name":"Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia"},{"name":"Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha R.","family":"FakhrEldeen","sequence":"additional","affiliation":[{"name":"Biochemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City 12585, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Saeed","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology Lecturer, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4619-685X","authenticated-orcid":false,"given":"Rania I.","family":"Nadeem","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology Department, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4309-7095","authenticated-orcid":false,"given":"Nancy S.","family":"Younis","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Department, Faculty of Clinical Pharmacy, King Faisal University, Al-Ahsa, Al-Hofuf 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa M.","family":"Abdel-Rahman","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Faculty of Pharmacy, Egyptian Russian University, Cairo 11829, Egypt"},{"name":"Department of Forensic Medicine and Toxicology, Faculty of Medicine, Ain Shams University, Cairo 11562, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad M.","family":"El-Dydamony","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City 12585, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lagard\u00e8re, P., Fersing, C., Masurier, N., and Lisowski, V. (2021). Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals, 15.","DOI":"10.3390\/ph15010035"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2015.08.018","article-title":"Recent Developments Regarding the Use of Thieno[2,3- d]Pyrimidin-4-One Derivatives in Medicinal Chemistry, with a Focus on Their Synthesis and Anticancer Properties","volume":"102","author":"Bozorov","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1700242","DOI":"10.1002\/ardp.201700242","article-title":"Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities","volume":"350","author":"Ghith","year":"2017","journal-title":"Arch. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/acph-2016-0005","article-title":"Synthesis and Structure Elucidation of Some Novel Thiophene and Benzothiophene Derivatives as Cytotoxic Agents","volume":"66","author":"Mohareb","year":"2016","journal-title":"Acta Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2019.07.017","article-title":"Discovery of Pyrazole-Thiophene Derivatives as Highly Potent, Orally Active Akt Inhibitors","volume":"180","author":"Zhan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/00304948.2017.1320513","article-title":"Newest Developments in the Preparation of Thieno[2,3-d]Pyrimidines","volume":"49","author":"Wilding","year":"2017","journal-title":"Org. Prep. Proced. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bmc.2019.02.044","article-title":"Thieno[2,3-d]Pyrimidine as a Promising Scaffold in Medicinal Chemistry: Recent Advances","volume":"27","author":"Ali","year":"2019","journal-title":"Bioorganic Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bioorg.2014.03.005","article-title":"Molecular Design and Synthesis of 1,4-Disubstituted Piperazines as A1-Adrenergic Receptor Blockers","volume":"54","author":"Hussein","year":"2014","journal-title":"Bioorganic Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1016\/j.bmcl.2009.08.059","article-title":"Thienopyrimidine-Based P2Y12 Platelet Aggregation Inhibitors","volume":"19","author":"Kortum","year":"2009","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_11","first-page":"986","article-title":"Study of the Antidepressant Activity of 4-Phenyl-2-Thioxo- Benzo[4,5]Thieno[2,3-d]Pyrimidine Derivatives","volume":"49","author":"Darias","year":"1999","journal-title":"Arzneim. Forsch. Drug Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jhet.3560","article-title":"Synthesis and Screening of Phosphodiesterase 5 Inhibitory Activity of Fused and Isolated Triazoles Based on Thieno[2,3-d]Pyrimidines","volume":"56","author":"Ameen","year":"2019","journal-title":"J. Heterocycl. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bioorg.2019.02.036","article-title":"Pyrazoles Containing Thiophene, Thienopyrimidine and Thienotriazolopyrimidine as COX-2 Selective Inhibitors: Design, Synthesis, in Vivo Anti-Inflammatory Activity, Docking and in Silico Chemo-Informatic Studies","volume":"85","author":"AboulWafa","year":"2019","journal-title":"Bioorganic Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bmcl.2015.12.083","article-title":"Synthesis, in Vitro Antimycobacterial Evaluation and Docking Studies of Some New 5,6,7,8-Tetrahydropyrido[4\u2032,3\u2032:4,5]Thieno[2,3-d]Pyrimidin-4(3H)-One Schiff Bases","volume":"26","author":"Narender","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.24820\/ark.5550190.p010.226","article-title":"Synthesis and Antimicrobial Activity of Some New Thienopyrimidine Derivatives","volume":"2017","author":"Tolba","year":"2017","journal-title":"Arkivoc"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/jm901284w","article-title":"Discovery of (Thienopyrimidin-2-Yl)Aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase\/MTOR Inhibitors for the Treatment of Cancer","volume":"53","author":"Sutherlin","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yu, L., Wang, Q., Wang, C., Zhang, B., Yang, Z., Fang, Y., Zhu, W., and Zheng, P. (2019). Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3K\u03b1 Inhibitors. Molecules, 24.","DOI":"10.3390\/molecules24193422"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"112024","DOI":"10.1016\/j.ejmech.2019.112024","article-title":"Design, Synthesis, Biological Evaluation and Molecular Docking Study of Novel Thieno[3,2-d]Pyrimidine Derivatives as Potent FAK Inhibitors","volume":"188","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1016\/j.bmcl.2009.10.001","article-title":"Novel Thienopyrimidine and Thiazolopyrimidine Kinase Inhibitors with Activity against Tie-2 in Vitro and in Vivo","volume":"19","author":"Luke","year":"2009","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1248\/cpb.c15-00277","article-title":"Synthesis, Anticancer Activity, Effect on Cell Cycle Profile, and Apoptosis-Inducing Ability of Novel Hexahydrocyclooctathieno[2,3-d]-Pyrimidine Derivatives","volume":"64","author":"Kassab","year":"2016","journal-title":"Chem. Pharm. Bull."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ejmech.2017.07.028","article-title":"Thienopyrimidine Derivatives Exert Their Anticancer Efficacy via Apoptosis Induction, Oxidative Stress and Mitotic Catastrophe","volume":"138","author":"Amawi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1016\/j.bmcl.2011.09.061","article-title":"Synthesis and Anti-Tumor Activities of N\u2032-Benzylidene-2-(4- Oxothieno[2,3-d]Pyrimidin-3(4H)-Yl)Acetohydrazone Derivatives","volume":"21","author":"Lou","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"112942","DOI":"10.1016\/j.ejmech.2020.112942","article-title":"Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality as Potential Inhibitors of Angiogenesis","volume":"209","author":"Faraji","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bmcl.2003.10.030","article-title":"Design and SAR of Thienopyrimidine and Thienopyridine Inhibitors of VEGFR-2 Kinase Activity","volume":"14","author":"Munchhof","year":"2004","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"112076","DOI":"10.1016\/j.ejmech.2020.112076","article-title":"Discovery of Novel Akt1 Inhibitor Induces Autophagy Associated Death in Hepatocellular Carcinoma Cells","volume":"189","author":"Yu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","first-page":"1016","article-title":"Revisiting the Hallmarks of Cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-009-9160-6","article-title":"Anti-Angiogenic Tyrosine Kinase Inhibitors: What Is Their Mechanism of Action?","volume":"13","author":"Gotink","year":"2010","journal-title":"Angiogenesis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000333256","article-title":"Signaling Pathways Governing Tumor Angiogenesis","volume":"81","author":"Sakurai","year":"2011","journal-title":"Oncology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.yexcr.2009.11.020","article-title":"VEGF Elicits Epithelial-Mesenchymal Transition (EMT) in Prostate Intraepithelial Neoplasia (PIN)-like Cells via an Autocrine Loop","volume":"316","author":"Lecanda","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/1381612033391405","article-title":"Role of Nitric Oxide in the Modulation of Angiogenesis","volume":"9","author":"Morbidelli","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","article-title":"Akt in Cancer: Mediator and More","volume":"59","author":"Revathidevi","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT Pathway in Cancer: The Framework of Malignant Behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bcp.13021","article-title":"AKT in Cancer: New Molecular Insights and Advances in Drug Development","volume":"82","author":"Mundi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc1651","article-title":"Killing Time for Cancer Cells","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rehan, M., Beg, M.A., Parveen, S., Damanhouri, G.A., and Zaher, G.F. (2014). Computational Insights into the Inhibitory Mechanism of Human AKT1 by an Orally Active Inhibitor, MK-2206. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109705"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yu, L., Wei, J., and Liu, P. (2021). Attacking the PI3K\/Akt\/MTOR Signaling Pathway for Targeted Therapeutic Treatment in Human Cancer. Semin. Cancer Biol., 21.","DOI":"10.1016\/j.semcancer.2021.06.019"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/1535-7163.MCT-08-0124","article-title":"Thymoquinone Inhibits Tumor Angiogenesis and Tumor Growth through Suppressing AKT and Extracellular Signal-Regulated Kinase Signaling Pathways","volume":"7","author":"Yi","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/MTOR Pathway in Angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"ref_41","first-page":"9377","article-title":"Inhibition of the PI3K\/Akt Signaling Pathway Reverses Sorafenib-Derived Chemo-Resistance in Hepatocellular Carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14756366.2022.2051022","article-title":"Pyrimidine-5-Carbonitrile Based Potential Anticancer Agents as Apoptosis Inducers through PI3K\/AKT Axis Inhibition in Leukaemia K562","volume":"37","author":"Abdelnaby","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_43","first-page":"38","article-title":"Synthesis, Properties and Biological Activity of Thiophene: A Review","volume":"4","author":"Mishra","year":"2011","journal-title":"Der. Pharma. Chem."},{"key":"ref_44","first-page":"2993","article-title":"Selective Cytotoxic Activities of Two Novel Synthetic Drugs on Human Breast Carcinoma MCF-7 Cells","volume":"29","author":"Badisa","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pharmthera.2016.12.001","article-title":"Maximising the Potential of AKT Inhibitors as Anti-Cancer Treatments","volume":"172","author":"Brown","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_46","first-page":"107","article-title":"The Role of Caspases in Apoptosis","volume":"62","author":"Harvey","year":"1998","journal-title":"Adv. Biochem Eng. Biotechnol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A Review of Programmed Cell Death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejmech.2014.01.063","article-title":"Part I. Synthesis, Biological Evaluation and Docking Studies of New 2-Furylbenzimidazoles as Antiangiogenic Agents","volume":"87","author":"Temirak","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1016\/j.bmc.2013.08.041","article-title":"Design and Bio-Evaluation of Indole Derivatives as Potent Kv1.5 Inhibitors","volume":"21","author":"Guo","year":"2013","journal-title":"Bioorganic Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104051","DOI":"10.1016\/j.bioorg.2020.104051","article-title":"Novel Antiproliferative Agents Bearing Morpholinopyrimidine Scaffold as PI3K Inhibitors and Apoptosis Inducers; Design, Synthesis and Molecular Docking","volume":"102","author":"Helwa","year":"2020","journal-title":"Bioorganic Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0166-0934(91)90008-N","article-title":"An Application of Tetrazolium (MTT) Colorimetric Assay for the Screening of Anti-Herpes Simplex Virus Compounds","volume":"33","author":"Takeuchi","year":"1991","journal-title":"J. Virol. Methods"},{"key":"ref_53","unstructured":"(2022, April 30). VEGFR-2 (Phospho-Tyr951) Colorimetric Cell-Based ELISA Kit. Available online: https:\/\/www.avivasysbio.com\/vegfr2-antibody-phospho-tyr951-oaec00085.html."},{"key":"ref_54","unstructured":"(2022, April 30). Mouse-Human-Rat-Phospho-Akt1-Ser473-Cell-Based-Phosphorylation-Elisa-Kit. Available online: https:\/\/www.lsbio.com\/elisakits\/mouse-human-rat-phospho-akt1-ser473-cell-based-phosphorylation-elisa-elisa-kit-ls-f1447\/1447."},{"key":"ref_55","unstructured":"(2022, April 30). Vegfr2-Kdr-Kinase-Assay-Kit-40325. Available online: https:\/\/bpsbioscience.com\/vegfr2-kdr-kinase-assay-kit-40325."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/bmc.3370","article-title":"Quantitation of VEGFR2 (Vascular Endothelial Growth Factor Receptor) Inhibitors\u2014Review of Assay Methodologies and Perspectives","volume":"29","author":"Sharma","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"ref_57","unstructured":"(2022, April 30). Akt-Kinase-Activity-Assay-Kit-Ab139436. Available online: https:\/\/www.abcam.com\/Akt-Kinase-Activity-Assay-Kit-ab139436.html?gclsrc=aw.ds|aw.ds&gclid=CjwKCAiA3L6PBhBvEiwAINlJ9LrLvZdlP_C1KmKmFjFeo-9yzmuKp8YmB30qig4O0SKaTnyXqcG9_hoCgKkQAvD_BwE."},{"key":"ref_58","first-page":"667","article-title":"Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_59","first-page":"301","article-title":"Analysis of Cell Cycle by Flow Cytometry","volume":"281","author":"Pozarowski","year":"2004","journal-title":"Methods Mol. Biol"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0037-1963(01)90051-4","article-title":"Flow Cytometry in Analysis of Cell Cycle and Apoptosis","volume":"38","author":"Darzynkiewicz","year":"2001","journal-title":"Semin. Hematol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A Novel Assay for Apoptosis Flow Cytometric Detection of Phosphatidylserine Expression on Early Apoptotic Cells Using Fluorescein Labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"374","DOI":"10.21769\/BioProtoc.374","article-title":"Protocol for Apoptosis Assay by Flow Cytometry Using Annexin V Staining Method","volume":"3","author":"Lakshmanan","year":"2013","journal-title":"Bio-Protocol"},{"key":"ref_63","unstructured":"(2022, April 30). Phosphoelisa-Caspase-3-Active-Human-Elisa-Kit\/KHO1091. Available online: https:\/\/www.fishersci.com\/shop\/products\/novex-phosphoelisa-caspase-3-active-human-elisa-kit\/KHO1091."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bioorg.2018.10.008","article-title":"Design, Synthesis and Molecular Modeling Study of Certain VEGFR-2 Inhibitors Based on Thienopyrimidne Scaffold as Cancer Targeting Agents","volume":"83","author":"Ghith","year":"2019","journal-title":"Bioorganic Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Alt\u0131ntop, M.D., Sever, B., Akal\u0131n, X.G., and Zdemir, A. (2018). Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors. Molecules, 23.","DOI":"10.3390\/molecules23061318"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/6\/700\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:23:57Z","timestamp":1760138637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/6\/700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ph15060700"],"URL":"https:\/\/doi.org\/10.3390\/ph15060700","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]}}}